{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:32:57Z","timestamp":1776108777192,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Carcinoma-associated fibroblasts (CAFs) are core components of the tumor microenvironment, which contribute to tumor initiation and progression through mediating immune suppression. In this study, eight activated CAF subpopulations were identified by single-cell sequencing (scRNA-seq). A specific subtype of CAFs, characterized by PCSK6 expression, strengthened PD-L1 membrane distribution, which contributed to the cytotoxic CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells exhaustion, subsequently promoting the progression of colorectal cancer (CRC). PCSK6 interacting with ACVR1B on CRC cell surface, promoting the acetylation modification of PD-L1 via acetyltransferase p300, followed by strengthened PD-L1 membrane distribution. Loss of PCSK6\/ACVR1B signaling in tumor stroma enhanced the intratumoral infiltration and activation of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells, alleviated growth of CRC and conferred survival advantage in tumor-bearing mice. Moreover, the membrane level of PD-L1 was mediated by the membrane transport complex Rab8\/EHBP1L1. Our finding suggested PCSK6\/ACVR1B-p300-Rab8\/EHBP1L1-PD-L1 signaling axis is significantly activated by CAFs-derived PCSK6, which may offer mechanism interpretation for CAFs mediated CRC immune escape and suggest potential mechanism-based therapeutic strategies for ACVR1B antagonist.\n                  <\/jats:p>","DOI":"10.1038\/s41418-026-01736-3","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:27:47Z","timestamp":1776097667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting CAFs-derived PCSK6 inhibits redistribution of PD-L1 and restores response of CD8+T cells against colorectal cancer"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-2899","authenticated-orcid":false,"given":"Qianming","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongting","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-399X","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"1736_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA A Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA A Cancer J Clin"},{"key":"1736_CR2","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1080\/13880209.2021.1942926","volume":"59","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang Q, Huang L, Liu M, Cheng Z, Zheng Y, et al. Pien-Tze-Huang attenuates neuroinflammation in cerebral ischaemia-reperfusion injury in rats through the TLR4\/NF-\u03baB\/MAPK pathway. Pharm Biol. 2021;59:826\u201337.","journal-title":"Pharm Biol"},{"key":"1736_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejca.2022.01.029","volume":"166","author":"H Swartjes","year":"2022","unstructured":"Swartjes H, Brouwer NP, de Nes LC, van Erning FN, Verhoeven RH, Vissers PA, et al. Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989. Eur J Cancer. 2022;166:134\u2013144.","journal-title":"Eur J Cancer"},{"key":"1736_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-022-00922-2","volume":"7","author":"H Zhou","year":"2022","unstructured":"Zhou H, Liu Z, Wang Y, Wen X, Amador EH, Yuan L, et al. Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduct Target Ther. 2022;7:70.","journal-title":"Signal Transduct Target Ther"},{"key":"1736_CR5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.21037\/jgo.2019.08.06","volume":"10","author":"AWC Kow","year":"2019","unstructured":"Kow AWC. Hepatic metastasis from colorectal cancer. J Gastrointest Oncol. 2019;10:1274\u201398.","journal-title":"J Gastrointest Oncol"},{"key":"1736_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/02656736.2022.2086712","volume":"39","author":"T Yang","year":"2022","unstructured":"Yang T, Chen Q, Kuang L, Fu Z, Wang Y, Chen Y, et al. Effectiveness and safety of ultrasound-guided high-intensity focused ultrasound ablation for the treatment of colorectal cancer liver metastases. Int J Hyperth. 2022;39:829\u201334.","journal-title":"Int J Hyperth"},{"key":"1736_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1736_CR8","doi-asserted-by":"publisher","first-page":"C233","DOI":"10.1152\/ajpcell.00079.2020","volume":"319","author":"H Huang","year":"2020","unstructured":"Huang H, Brekken RA. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer. Am J Physiol-Cell Physiol. 2020;319:C233\u201343.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"1736_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-022-02524-w","volume":"41","author":"S Rizzolio","year":"2022","unstructured":"Rizzolio S, Giordano S, Corso S. The importance of being CAFs (in cancer resistance to targeted therapies). J Exp Clin Cancer Res. 2022;41:1\u201316.","journal-title":"J Exp Clin Cancer Res"},{"key":"1736_CR10","first-page":"1","volume":"23","author":"AM Khaliq","year":"2022","unstructured":"Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, et al. Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biol. 2022;23:1\u201330.","journal-title":"Genome Biol"},{"key":"1736_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.833797","volume":"13","author":"A Jiang","year":"2022","unstructured":"Jiang A, Wang J, Liu N, Zheng X, Li Y, Ma Y, et al. Integration of single-cell RNA sequencing and bulk RNA sequencing data to establish and validate a prognostic model for patients with lung adenocarcinoma. Front Genet. 2022;13:833797.","journal-title":"Front Genet"},{"key":"1736_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01264-9","volume":"19","author":"X Ma","year":"2020","unstructured":"Ma X, Guo J, Liu K, Chen L, Liu D, Dong S, et al. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing. Mol Cancer. 2020;19:1\u201317.","journal-title":"Mol Cancer"},{"key":"1736_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41596-020-00409-w","volume":"16","author":"TS Andrews","year":"2021","unstructured":"Andrews TS, Kiselev VY, McCarthy D, Hemberg M. Tutorial: guidelines for the computational analysis of single-cell RNA sequencing data. Nat Protoc. 2021;16:1\u20139.","journal-title":"Nat Protoc"},{"key":"1736_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/cancers15010241","volume":"15","author":"H He","year":"2022","unstructured":"He H, Zhang S, Yang H, Xu P, Kutschick I, Pfeffer S, et al. Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator. Cancers. 2022;15:241.","journal-title":"Cancers"},{"key":"1736_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","volume":"5","author":"H Sugimoto","year":"2006","unstructured":"Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther. 2006;5:1640\u20136.","journal-title":"Cancer Biol Ther"},{"key":"1736_CR16","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/cas.13991","volume":"110","author":"Q Wang","year":"2019","unstructured":"Wang Q, Zhang YC, Zhu LF, Pan L, Yu M, Shen WL, et al. Heat shock factor 1 in cancer-associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma. Cancer Sci. 2019;110:1790\u20131803.","journal-title":"Cancer Sci"},{"key":"1736_CR17","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30:R921\u20135.","journal-title":"Curr Biol"},{"key":"1736_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio M, Hu T, Pai C-C, Chu B, Belair CD, Chang A, et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell. 2019;177:414\u201327.","journal-title":"Cell"},{"key":"1736_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","volume":"7","author":"S Shang","year":"2022","unstructured":"Shang S, Liu J, Hua F. Protein acylation: mechanisms, biological functions and therapeutic targets. Signal Transduct Target Ther. 2022;7:396.","journal-title":"Signal Transduct Target Ther"},{"key":"1736_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160456","volume":"133","author":"X Yu","year":"2023","unstructured":"Yu X, Li W, Liu H, Wang X, Coarfa C, Cheng C, et al. PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination. J Clin Investig. 2023;133:e160456.","journal-title":"J Clin Investig"},{"key":"1736_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/ijms24010126","volume":"24","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wu F, Yan Q, Duan Z, Wang S, Ao B, et al. Genome-wide analysis of the Rab gene family in melilotus albus reveals their role in salt tolerance. Int J Mol Sci. 2023;24:126.","journal-title":"Int J Mol Sci"},{"key":"1736_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/febs.15453","volume":"288","author":"Y Homma","year":"2021","unstructured":"Homma Y, Hiragi S, Fukuda M. Rab family of small GTPases: an updated view on their regulation and functions. FEBS J. 2021;288:36\u201355.","journal-title":"FEBS J"},{"key":"1736_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s43032-020-00256-w","volume":"28","author":"NL Leiva","year":"2021","unstructured":"Leiva NL, Nolly MB, \u00c1vila Maniero M, Losinno AD, Damiani MT. Rab proteins: insights into intracellular trafficking in endometrium. Reprod Sci. 2021;28:12\u201322.","journal-title":"Reprod Sci"},{"key":"1736_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/biomedicines11010112","volume":"11","author":"R Sulaiman","year":"2023","unstructured":"Sulaiman R, De P, Aske JC, Lin X, Dale A, Koirala N, et al. Patient-derived primary cancer-associated fibroblasts mediate resistance to anti-angiogenic drug in ovarian cancers. Biomedicines. 2023;11:112.","journal-title":"Biomedicines"},{"key":"1736_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s10120-021-01259-5","volume":"25","author":"T Zhang","year":"2022","unstructured":"Zhang T, Li X, He Y, Wang Y, Shen J, Wang S, et al. Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer. Gastric Cancer. 2022;25:346\u201359.","journal-title":"Gastric Cancer"},{"key":"1736_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9:1102\u201323.","journal-title":"Cancer Discov"},{"key":"1736_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12:1\u201315.","journal-title":"J Hematol Oncol"},{"key":"1736_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735\u201347.","journal-title":"Cancer Cell"},{"key":"1736_CR29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, et al. Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40:1550\u201365.e1557.","journal-title":"Cancer Cell"},{"key":"1736_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.devcel.2020.10.014","volume":"56","author":"H Kasashima","year":"2021","unstructured":"Kasashima H, Duran A, Martinez-Ordo\u00f1ez A, Nakanishi Y, Kinoshita H, Linares JF, et al. Stromal SOX2 upregulation promotes tumorigenesis through the generation of a SFRP1\/2-expressing cancer-associated fibroblast population. Develop Cell. 2021;56:95\u2013110.e110.","journal-title":"Develop Cell"},{"key":"1736_CR31","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41388-021-02175-9","volume":"41","author":"Z He","year":"2022","unstructured":"He Z, Khatib A-M, Creemers JW. The proprotein convertase furin in cancer: more than an oncogene. Oncogene. 2022;41:1252\u201362.","journal-title":"Oncogene"},{"key":"1736_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCRESAHA.120.316612","volume":"126","author":"HF J\u00f8rgensen","year":"2020","unstructured":"J\u00f8rgensen HF, Bennett MR. PCSK6-mediated regulation of vascular remodeling. Circul Res. 2020;126:586\u201388.","journal-title":"Circul Res"},{"key":"1736_CR33","doi-asserted-by":"publisher","first-page":"13429","DOI":"10.3390\/ijms232113429","volume":"23","author":"Q Wu","year":"2022","unstructured":"Wu Q, Chen S. Proprotein convertase subtilisin\/Kexin 6 in cardiovascular biology and disease. Int J Mol Sci. 2022;23:13429.","journal-title":"Int J Mol Sci"},{"key":"1736_CR34","first-page":"145","volume":"16","author":"P Wang","year":"2018","unstructured":"Wang P, Wang F, Wang L, Pan J. Proprotein convertase subtilisin\/kexin type 6 activates the extracellular signal\u2011regulated kinase 1\/2 and Wnt family member 3A pathways and promotes in vitro proliferation, migration and invasion of breast cancer MDA\u2011MB\u2011231 cells. Oncol Lett. 2018;16:145\u2013150.","journal-title":"Oncol Lett"},{"key":"1736_CR35","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/ijc.32278","volume":"145","author":"Z Li","year":"2019","unstructured":"Li Z, Zhou J, Zhang J, Li S, Wang H, Du J. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. Int J Cancer. 2019;145:1946\u201357.","journal-title":"Int J Cancer"},{"key":"1736_CR36","doi-asserted-by":"crossref","unstructured":"Li S-M, Zhou J, Wang Y, Nie R-C, Chen J-W, Xie D Recent findings in the posttranslational modifications of PD-L1. J Oncol 2020:5497015.","DOI":"10.1155\/2020\/5497015"},{"key":"1736_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216796120","volume":"120","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Wang H, Chai S, Xu L, Lin B, Yi W, et al. O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation. Proc Natl Acad Sci USA 2023;120:e2216796120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12632","volume":"7","author":"C-W Li","year":"2016","unstructured":"Li C-W, Lim S-O, Xia W, Lee H-H, Chan L-C, Kuo C-W, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7:12632.","journal-title":"Nat Commun"},{"key":"1736_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114851119","volume":"119","author":"R Zhang","year":"2022","unstructured":"Zhang R, Yang Y, Dong W, Lin M, He J, Zhang X, et al. D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. Proc Natl Acad Sci USA 2022;119:e2114851119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR40","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1172\/JCI126022","volume":"129","author":"L-C Chan","year":"2019","unstructured":"Chan L-C, Li C-W, Xia W, Hsu J-M, Lee H-H, Cha J-H, et al. IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. J Clin Investig. 2019;129:3324\u201338.","journal-title":"J Clin Investig"},{"key":"1736_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/cells14020069","volume":"14","author":"AB Awan","year":"2025","unstructured":"Awan AB, Osman MJA, Khan OM. Ubiquitination enzymes in cancer, cancer immune evasion, and potential therapeutic opportunities. Cells. 2025;14:69.","journal-title":"Cells"},{"key":"1736_CR42","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/cancers17101635","volume":"17","author":"D Escors","year":"2025","unstructured":"Escors D, Chocarro L, Echaide M, Rodriguez-Neira C, Vilaplana B, Kochan G. Programmed death-1 ligand 1 domain organization, signaling motifs, and interactors in cancer immunotherapy. Cancers. 2025;17:1635.","journal-title":"Cancers"},{"key":"1736_CR43","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41556-020-0562-4","volume":"22","author":"Y Gao","year":"2020","unstructured":"Gao Y, Nihira NT, Bu X, Chu C, Zhang J, Kolodziejczyk A, et al. Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy. Nat Cell Biol. 2020;22:1064\u201375.","journal-title":"Nat Cell Biol"},{"key":"1736_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/imm.13573","volume":"167","author":"S Zhou","year":"2022","unstructured":"Zhou S, Zhu J, Xu J, Gu B, Zhao Q, Luo C, et al. Anti-tumour potential of PD-L1\/PD-1 post-translational modifications. Immunology. 2022;167:471\u201381.","journal-title":"Immunology"},{"key":"1736_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12672-023-00766-4","volume":"14","author":"MA Romeo","year":"2023","unstructured":"Romeo MA, Gilardini Montani MS, Santarelli R, Benedetti R, Arena A, Cirone M. Acetylation increases expression, interaction with TRAPPC4 and surface localization of PD-L1. Discov Oncol. 2023;14:152.","journal-title":"Discov Oncol"},{"key":"1736_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat3504","volume":"10","author":"KD Marini","year":"2018","unstructured":"Marini KD, Croucher DR, McCloy RA, Vaghjiani V, Gonzalez-Rajal A, Hastings JF, et al. Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy. Sci Transl Med. 2018;10:eaat3504.","journal-title":"Sci Transl Med"},{"key":"1736_CR47","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/1535-7163.MCT-13-0903","volume":"13","author":"JY Son","year":"2014","unstructured":"Son JY, Park S-Y, Kim S-J, Lee SJ, Park S-A, Kim M-J, et al. EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis. Mol Cancer Therapeutics. 2014;13:1704\u201316.","journal-title":"Mol Cancer Therapeutics"},{"key":"1736_CR48","doi-asserted-by":"publisher","first-page":"15635","DOI":"10.1073\/pnas.1904714116","volume":"116","author":"H Takeda","year":"2019","unstructured":"Takeda H, Kataoka S, Nakayama M, Ali MA, Oshima H, Yamamoto D, et al. CRISPR-Cas9\u2013mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes. Proc Natl Acad Sci USA 2019;116:15635\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0456-4","volume":"14","author":"J Bauer","year":"2015","unstructured":"Bauer J, Ozden O, Akagi N, Carroll T, Principe DR, Staudacher JJ, et al. Activin and TGF-\u03b2 use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:1\u201314.","journal-title":"Mol Cancer"},{"key":"1736_CR50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.5009\/gnl220531","volume":"18","author":"H Peng","year":"2023","unstructured":"Peng H, Ye T, Deng L, Yang X, Li Q, Tong J, et al. Activin and hepatocyte growth factor promotes colorectal cancer stemness and metastasis through FOXM1\/SOX2\/CXCR4 signaling. Gut Liver. 2023;18:476.","journal-title":"Gut Liver"},{"key":"1736_CR51","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"NP Du Sert","year":"2020","unstructured":"Du Sert NP, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18:e3000411.","journal-title":"PLoS Biol"},{"key":"1736_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ijc.22594","volume":"121","author":"DL Gorden","year":"2007","unstructured":"Gorden DL, Fingleton B, Crawford HC, Jansen DE, Lepage M, Matrisian LM. Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. Int J Cancer. 2007;121:495\u2013500.","journal-title":"Int J Cancer"},{"key":"1736_CR53","doi-asserted-by":"publisher","first-page":"e0226129","DOI":"10.1371\/journal.pone.0226129","volume":"14","author":"S-F Yang","year":"2019","unstructured":"Yang S-F, Chou R-H, Lin S-J, Li S-Y, Huang P-H. Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography. Plos One. 2019;14:e0226129.","journal-title":"Plos One"},{"key":"1736_CR54","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216373","volume":"15","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Lei Y, Ning H, Zhang Y, Chen G, Wang C, et al. PGF2\u03b1 facilitates pathological retinal angiogenesis by modulating endothelial FOS-driven ELR+ CXC chemokine expression. EMBO Mol Med. 2023;15:e16373.","journal-title":"EMBO Mol Med"},{"key":"1736_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114438","volume":"281","author":"W Lei","year":"2021","unstructured":"Lei W, Li X, Li L, Huang M, Cao Y, Sun X, et al. Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K\/AKT and PPAR signaling pathways. J Ethnopharmacol. 2021;281:114438.","journal-title":"J Ethnopharmacol"},{"key":"1736_CR56","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pharep.2017.01.024","volume":"69","author":"T Naruse","year":"2017","unstructured":"Naruse T, Aoki M, Fujimoto N, Arase S, Oura H, Ueda Y, et al. Novel ALK5 inhibitor TP0427736 reduces TGF-\u03b2 induced growth inhibition in human outer root sheath cells and elongates anagen phase in mouse hair follicles. Pharmacol Rep. 2017;69:485\u201391.","journal-title":"Pharmacol Rep"},{"key":"1736_CR57","doi-asserted-by":"publisher","first-page":"103167","DOI":"10.18632\/oncotarget.21704","volume":"8","author":"J Zhou","year":"2017","unstructured":"Zhou J, Zhao T, Ma L, Liang M, Guo Y-J, Zhao L-M. Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K\/Akt\/mTOR, STAT3 and ERK signaling. Oncotarget. 2017;8:103167.","journal-title":"Oncotarget"},{"key":"1736_CR58","doi-asserted-by":"publisher","first-page":"10204","DOI":"10.3390\/ijms221910204","volume":"22","author":"M Kopczynski","year":"2021","unstructured":"Kopczynski M, Rumienczyk I, Kulecka M, Statkiewicz M, Pysniak K, Sandowska-Markiewicz Z, et al. Selective extracellular signal-regulated kinase 1\/2 (ERK1\/2) inhibition by the SCH772984 compound attenuates In vitro and In vivo inflammatory responses and prolongs survival in murine sepsis models. Int J Mol Sci. 2021;22:10204.","journal-title":"Int J Mol Sci"},{"key":"1736_CR59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/chem.201904147","volume":"26","author":"K Natarajan","year":"2020","unstructured":"Natarajan K, M\u00fcller-Klieser D, Rubner S, Berg T. Stafia-1: a STAT5a-selective inhibitor developed via docking-based screening of in Silico O-phosphorylated fragments. Chem-A Eur J. 2020;26:148\u2013154.","journal-title":"Chem-A Eur J"},{"key":"1736_CR60","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jcmm.17687","volume":"27","author":"B Liang","year":"2023","unstructured":"Liang B, Jiang Y, Song S, Jing W, Yang H, Zhao L, et al. ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT\/\u03b2-catenin\/HK2 axis. J Cell Mol Med. 2023;27:659\u201371.","journal-title":"J Cell Mol Med"},{"key":"1736_CR61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jss.2005.04.038","volume":"129","author":"C Chao","year":"2005","unstructured":"Chao C, Tallman ML, Ives KL, Townsend JrCM, Hellmich MR. Gastrointestinal hormone receptors in primary human colorectal carcinomas1. J Surg Res. 2005;129:313\u201321.","journal-title":"J Surg Res"},{"key":"1736_CR62","doi-asserted-by":"crossref","unstructured":"Kitamura T, Doughty-Shenton D, Pollard JW, Carragher NO Real time detection of in vitro tumor cell apoptosis induced by CD8+ T cells to study immune suppressive functions of tumor-infiltrating myeloid cells. JoVE 2019:e58841.","DOI":"10.3791\/58841-v"},{"key":"1736_CR63","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.cmet.2024.05.013","volume":"36","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Wang Y, Chen G, Sun F, Wu Q, Huang Q, et al. Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer. Cell Metab. 2024;36:1806\u201322.","journal-title":"Cell Metab"},{"key":"1736_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207693","volume":"10","author":"H Kim","year":"2023","unstructured":"Kim H, Villareal LB, Liu Z, Haneef M, Falcon DM, Martin DR, et al. Transferrin receptor-mediated iron uptake promotes colon tumorigenesis. Adv Sci. 2023;10:2207693.","journal-title":"Adv Sci"},{"key":"1736_CR65","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang Z, Kim SY, Tu W, Kim J, Xu A, Yang YM, et al. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. Cell Metab. 2023;35:1209\u201326.","journal-title":"Cell Metab"},{"key":"1736_CR66","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.devcel.2023.04.014","volume":"58","author":"J Zhao","year":"2023","unstructured":"Zhao J, Yang S, Xu Y, Qin S, Bie F, Chen L, et al. Mechanical pressure-induced dedifferentiation of myofibroblasts inhibits scarring via SMYD3\/ITGBL1 signaling. Develop Cell. 2023;58:1139\u201352.","journal-title":"Develop Cell"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01736-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:02:28Z","timestamp":1776103348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01736-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":66,"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01736-3","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}